MoneyWorks4Me

Sequent Scientific - Quaterly Results

13 Nov 2024 Evaluate
Net sales declined -14.52%  to  Rs. 419.90 million from Rs. 491.20 millions.The Total Profit for the quarter ended September 2024 of Rs. 42.60 millions grew from Rs.-9.20 millionsOperating profit for the quarter ended September 2024 rose to 138.50 millions as compared to 21.60 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 419.90 491.20 -14.52 996.60 895.40 11.30 1685.18 2226.85 -24.32
Other Income 159.50 98.70 61.60 267.90 195.70 36.89 459.80 282.42 62.81
PBIDT 138.50 21.60 541.20 227.10 27.90 713.98 193.16 18.82 926.35
Interest 10.00 12.10 -17.36 18.10 21.90 -17.35 43.61 25.13 73.54
PBDT 85.30 9.50 797.89 165.80 -56.50 -393.45 87.01 -6.31 -1478.92
Depreciation 21.20 23.50 -9.79 41.20 47.80 -13.81 89.40 91.15 -1.92
PBT 64.10 -14.00 -557.86 124.60 -104.30 -219.46 -2.39 -97.46 -97.55
TAX 21.50 -4.80 -547.92 37.00 -27.10 -236.53 -8.61 -36.66 -76.51
Deferred Tax 10.80 -19.80 -154.55 16.60 -27.10 -161.25 -13.20 -30.94 -57.34
PAT 42.60 -9.20 -563.04 87.60 -77.20 -213.47 6.22 -60.80 -110.23
Equity 499.20 498.90 0.06 499.20 498.90 0.06 498.86 498.86 0.00
PBIDTM(%) 32.98 4.40 650.08 22.79 3.12 631.33 11.46 0.85 1256.32
Peers
Company Name CMP
Sun Pharma. Inds. 1847.15
Dr. Reddys Labs. 1210.55
Cipla 1367.55
Lupin 2120.80
Zydus Lifesciences 1167.70
View more..